loader
Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for Insulin (bovine) Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

    Stock Recap
    #PipelineProspector

    Menu

    Insulin (bovine)

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    26/09/2024 Laboratorios Beta S.A. AR C1232 AAR Buenos Aires
    Argentina
    		 Laboratorios Beta S.A. Buenos Aires AR R1-CEP 2005-214 - Rev 00 Insulin, bovine 2011-01-07 Valid TSE
    26/09/2024 Novo Nordisk
    Denmark
    		 Novo Nordisk Produção Farmacêutica do Brasil Ltda Montes Claros BR R1-CEP 2000-230 - Rev 00 Insulin, bovine 2006-05-17 Valid TSE